Health-Related Quality of Life in Patients With Bladder Cancer
NCT00744744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138
Last updated 2012-02-02
Summary
RATIONALE: Gathering information about quality of life in patients with cancer may improve the ability to plan treatment and may help patients live more comfortably.
PURPOSE: This clinical trial is studying health-related quality of life in patients with bladder cancer.
Conditions
Interventions
- OTHER
-
informational intervention
Patient educational information
- OTHER
-
questionnaire administration
Survey
- PROCEDURE
-
management of therapy complications
Survey
- PROCEDURE
-
psychosocial assessment and care
Survey
- PROCEDURE
-
quality-of-life assessment
Survey
Sponsors & Collaborators
-
David Latini
lead OTHER
Principal Investigators
-
David M. Latini, PhD · Baylor College of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
An Educational Intervention for Patients With Bladder Cancer
NCT01915121 ·Status: COMPLETED ·Phase: NA
-
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
NCT05195515 ·Status: ENROLLING_BY_INVITATION
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
NCT07048496 ·Status: RECRUITING ·Phase: NA
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Recovery Support for Bladder Cancer Patients and Caregivers
NCT04055311 ·Status: COMPLETED ·Phase: NA
-
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
NCT05327647 ·Status: RECRUITING ·Phase: PHASE2
-
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NCT05739968 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
NCT02145390 ·Status: TERMINATED ·Phase: NA
-
Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
NCT02381912 ·Status: COMPLETED
-
The Personal Patient Profile Decision Support for Patients With Bladder Cancer
NCT05033067 ·Status: COMPLETED ·Phase: NA
-
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
NCT07225127 ·Status: RECRUITING
-
The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer
NCT02716623 ·Status: COMPLETED ·Phase: NA
-
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
NCT03317158 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
NCT06337305 ·Status: COMPLETED
-
Bladder Cancer and ExeRcise Training During IntraVesical ThErapy
NCT04593862 ·Status: COMPLETED ·Phase: PHASE2
-
To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).
NCT05236218 ·Status: UNKNOWN
-
Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer
NCT02688348 ·Status: WITHDRAWN ·Phase: NA
-
Markers of Response to Intravesical Bladder Cancer Therapy
NCT01007058 ·Status: COMPLETED
-
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
NCT04701918 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
NCT01373294 ·Status: COMPLETED ·Phase: PHASE2
-
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982 ·Status: RECRUITING
-
Drug Screening Using IMD in Bladder Cancer
NCT06204614 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
NCT07342517 ·Status: WITHDRAWN ·Phase: PHASE3